A new look at the etiology of interstitial cystitis/bladder pain syndrome: extraordinary cultivations.


Journal

International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 25 04 2019
accepted: 24 07 2019
pubmed: 1 8 2019
medline: 28 2 2020
entrez: 1 8 2019
Statut: ppublish

Résumé

So far, studies have not clearly identified infectious agents as an etiological factor for interstitial cystitis (IC). Specific microbiological diagnosis for detecting the pathogen with higher sensitivity in IC may decrease the treatment costs and increase psychosocial health of the patients. A prospective clinical study was performed in 26 IC patients and 20 controls between April and September 2017. All participants were asked to give mid-stream urine sample for routine urine cultures. Followed by the negative results, symptomatic 26 patients were evaluated for L-form pathogen existence by extraordinary cultivation methods. Biopsy samples were taken from 19 patients with ulcerative lesions in the bladder while collecting sterile urine samples from all 26 patients. PG broth, 5% sheep blood agar, EMB, Sabouraud's dextrose, LEM, and GYPA were used. Followed by the 1st day inoculations, all inoculated PG broths were subcultured into the same solid media at the 2nd and 10th days in case of any growth after incubation of 24 h under 35-37 °C. The "O'Leary Sant Symptom and Problem Index" score forms were used to evaluate response to the appropriate treatment for those patients with documented pathogens. Bacterial isolations were yielded from samples of 13 IC patients in PG broth. Eight (61.5%) P. aeruginosa, 2 (15.4%) K. pneumoniae, 2 (15.4%) C. mucifaciens, and 1 (7.7%) E. faecalis were isolated. Antibiotic susceptibility tests were performed. Somehow, the median symptom index and problem scores of those 13 IC patients were lower after the appropriate antibiotic treatment (p < 0.05). Extraordinary mediums with longer incubation periods may reveal a causative pathogen in the etiology of IC. Future culture techniques may have some value, because still some of IC/BPS patients are describing symptomatic relief by a group of antibiotics.

Identifiants

pubmed: 31363960
doi: 10.1007/s11255-019-02248-5
pii: 10.1007/s11255-019-02248-5
doi:

Types de publication

Clinical Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1961-1967

Subventions

Organisme : Hacettepe University Scientific Research Projects Coordination Unit
ID : TTU-2017-13216

Références

Int Urogynecol J. 2010 Jan;21(1):103-9
pubmed: 19760079
Urology. 1995 Feb;45(2):223-9
pubmed: 7855970
Philos Trans R Soc Lond B Biol Sci. 2016 Nov 5;371(1707):
pubmed: 27672147
Urology. 2015 Sep;86(3):425-31
pubmed: 26189137
Can Urol Assoc J. 2016 May-Jun;10(5-6):E136-E155
pubmed: 27790294
World J Urol. 2009 Dec;27(6):717-21
pubmed: 19551386
Arch Gynecol Obstet. 2017 Jun;295(6):1341-1359
pubmed: 28391486
Helicobacter. 2015 Apr;20(2):98-105
pubmed: 25381932
J Urol. 2015 May;193(5):1545-53
pubmed: 25623737
J Clin Invest. 1965 Dec;44(12):1945-52
pubmed: 4954866
Mikrobiologiia. 2015 Nov-Dec;84(6):645-59
pubmed: 26964354
Clin Infect Dis. 2004 Apr 15;38(8):1150-8
pubmed: 15095222
J Urol. 1995 Apr;153(4):1321-6
pubmed: 7869536
Urol Clin North Am. 1994 Feb;21(1):7-20
pubmed: 8284848
Lab Med. 2015 Spring;46(2):136-9
pubmed: 25918192
J Urol. 2011 Aug;186(2):540-4
pubmed: 21683389
Int J Urol. 2014 Apr;21 Suppl 1:85-8
pubmed: 24807511
Int J Surg. 2013;11(3):233-7
pubmed: 23419614
J Bacteriol. 2007 Sep;189(18):6512-20
pubmed: 17586646
Oxid Med Cell Longev. 2018 Mar 21;2018:7924021
pubmed: 29743986

Auteurs

Tahsin Batuhan Aydogan (TB)

Department of Urology, Hacettepe University Faculty of Medicine, Ankara, Turkey. drbatu@hotmail.com.

Oznur Gurpinar (O)

Department of Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Ozgen Koseoglu Eser (OK)

Department of Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Begum Aydogan Mathyk (BA)

Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, USA.

Ali Ergen (A)

Department of Urology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH